Celltrion Pharm

068760.KQ

34.62 USD

-0.60

-1.70%

Overview

Last close

34.62 usd

Market cap

1.43B usd

52 week high

93.83 usd

52 week low

33.02 usd

Target price

92.53 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

8.0362

Price/Book Value

5.5622

Enterprise Value

1.57B usd

EV/Revenue

4.835

EV/EBITDA

40.2797

Key financials

Revenue TTM

186.91M usd

Gross Profit TTM

49.62M usd

EBITDA TTM

29.12M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

454.19M usd

Net debt

74.22M usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.